The serum concentration of AFP is over-expressed in conditions such as HCC, hepatoblastoma and teratoma in adults, featuring this protein as a valuable serum marker for tumor diagnosis and drug resistance and for monitoring therapeutic efficacy [105,106]. This evidence concerns the gene AFP and hepatocellular carcinoma.